are glp 1 considered specialty drugs GLP-1 Drug Savings: A Complete Guide for How to Save on Ozempic, Wegovy, and More Perspectives from employers on the

[3] Foundayo (orforglipron), approved by the FDA on April 1, 2026, changes that calculus

The findings have not yet undergone peer review

The risk of hospitalization for heart failure remains poorly understood, and risk factors such as prior heart failure and chronic kidney disease should be considered when prescribing this class of therapy [47]

A novel anti-inflammatory mechanism

I keep an eye on this space because, despite considerable issues with nausea, vomiting, muscle loss, and even rare cases of sudden blindness, the GLP-1 RA drugs may offer the first real hope for patients with metabolic syndrome associated with chronic ulcers

Importantly, the largest reductions in BMI were observed in the southern United States, which also reported the highest rates of GLP-1 RA dispensing claims (Rader et al., 2024), a geographic concordance that is consistent with a causal contribution of these pharmacotherapies to the observed population-level BMI decline